- Home
- SGHT vs GHI Comparison
SGHT vs GHI Comparison
Compare SGHT & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- GHI
- Stock Information
- Founded
- SGHT 2011
- GHI 1998
- Country
- SGHT United States
- GHI United States
- Employees
- SGHT N/A
- GHI N/A
- Industry
- SGHT Medical Specialities
- GHI Finance: Consumer Services
- Sector
- SGHT Health Care
- GHI Finance
- Exchange
- SGHT Nasdaq
- GHI Nasdaq
- Market Cap
- SGHT 222.3M
- GHI 269.5M
- IPO Year
- SGHT 2021
- GHI N/A
- Fundamental
- Price
- SGHT $4.21
- GHI $11.48
- Analyst Decision
- SGHT Buy
- GHI Strong Buy
- Analyst Count
- SGHT 8
- GHI 4
- Target Price
- SGHT $4.01
- GHI $16.00
- AVG Volume (30 Days)
- SGHT 167.1K
- GHI 49.2K
- Earning Date
- SGHT 07-31-2025
- GHI 08-06-2025
- Dividend Yield
- SGHT N/A
- GHI 12.89%
- EPS Growth
- SGHT N/A
- GHI N/A
- EPS
- SGHT N/A
- GHI 0.45
- Revenue
- SGHT $78,109,000.00
- GHI $34,065,322.00
- Revenue This Year
- SGHT N/A
- GHI $228.92
- Revenue Next Year
- SGHT $11.60
- GHI $4.27
- P/E Ratio
- SGHT N/A
- GHI $25.65
- Revenue Growth
- SGHT N/A
- GHI N/A
- 52 Week Low
- SGHT $2.03
- GHI $10.12
- 52 Week High
- SGHT $8.45
- GHI $15.27
- Technical
- Relative Strength Index (RSI)
- SGHT 57.43
- GHI 45.71
- Support Level
- SGHT $4.00
- GHI $11.10
- Resistance Level
- SGHT $4.34
- GHI $11.67
- Average True Range (ATR)
- SGHT 0.22
- GHI 0.36
- MACD
- SGHT -0.04
- GHI -0.07
- Stochastic Oscillator
- SGHT 47.21
- GHI 40.88
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.